Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
about
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticlesBreast cancer medications and vision: effects of treatments for early-stage disease.Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and AlternativeAnti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3).Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
P2860
Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategies to decrease taxanes ...... atment of early breast cancer.
@en
Strategies to decrease taxanes ...... atment of early breast cancer.
@nl
type
label
Strategies to decrease taxanes ...... atment of early breast cancer.
@en
Strategies to decrease taxanes ...... atment of early breast cancer.
@nl
prefLabel
Strategies to decrease taxanes ...... atment of early breast cancer.
@en
Strategies to decrease taxanes ...... atment of early breast cancer.
@nl
P2860
P1433
P1476
Strategies to decrease taxanes ...... atment of early breast cancer.
@en
P2093
Shou-Ching Tang
P2860
P304
P356
10.1080/07357900802178520
P577
2009-02-01T00:00:00Z